TEVATeva- Pharmaceutical Industries Ltd. - ADR
TEVA
Teva- Pharmaceutical Industries Ltd. - ADR26,949
Mkt Cap
$33.46BVolume
6.29M52W High
$37.3552W Low
$12.47PE Ratio
23.60TEVA Fundamentals
Price
$28.73Prev Close
$29.44Open
$29.6450D MA
$32.63Beta
0.80Avg. Volume
8.38MEPS (Annual)
$1.22P/B
4.18Rev/Employee
$523,613.72$49,934.02
Hudson Bay Capital Management LP Acquires 105,000 Shares of Teva Pharmaceutical Industries Ltd. $TEVA
Hudson Bay Capital Management LP grew its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 87.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 225,000 shares of the company's...
MarketBeat·6h ago
Mark Sabag Sells 62,102 Shares of Teva Pharmaceutical Industries (NYSE:TEVA) Stock
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) insider Mark Sabag sold 62,102 shares of the company's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $30.14, for a total value of $1,871,754.28. Following the transaction, the insider owned...
MarketBeat·2d ago
Union Bancaire Privee UBP SA Grows Stock Position in Teva Pharmaceutical Industries Ltd. $TEVA
Union Bancaire Privee UBP SA grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 3,831.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 786,272 shares of the company's stock after ac...
MarketBeat·2d ago
Teva Pharmaceutical Industries (NYSE:TEVA) Insider Sells $1,871,754.28 in Stock
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) insider Mark Sabag sold 62,102 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $30.14, for a total transaction of $1,871,754.28. Following the completion of the sale, the...
MarketBeat·3d ago
Cantor Fitzgerald L. P. Purchases New Shares in Teva Pharmaceutical Industries Ltd. $TEVA
Cantor Fitzgerald L. P. acquired a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 68,890 shares of the company's stock, value...
MarketBeat·3d ago
Achmea Investment Management B.V. Decreases Stock Position in Teva Pharmaceutical Industries Ltd. $TEVA
Achmea Investment Management B.V. cut its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 40.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 403,824 shares of the co...
MarketBeat·3d ago
Militia Capital Partners LP Invests $1.82 Million in Teva Pharmaceutical Industries Ltd. $TEVA
Militia Capital Partners LP acquired a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·5d ago
Investors Buy High Volume of Teva Pharmaceutical Industries Call Options (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) was the target of unusually large options trading on Monday. Stock traders acquired 33,840 call options on the company. This...
MarketBeat·6d ago
Teva Pharmaceutical Industries Ltd. $TEVA Holdings Reduced by Ion Asset Management Ltd.
Ion Asset Management Ltd. lowered its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 85.6% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·6d ago
Brevan Howard Capital Management LP Acquires New Position in Teva Pharmaceutical Industries Ltd. $TEVA
Brevan Howard Capital Management LP bought a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the third quarter, according to its most recent 13F filing with the...
MarketBeat·6d ago
<
1
2
...
>